Revolution Medicines (RVMDW) Return on Sales (2019 - 2024)
Revolution Medicines (RVMDW) posted quarterly Return on Sales of 7.69% for Q3 2024, down 757.0% year-over-year from 1.17% in Q4 2023, and down 9.15% quarter-over-quarter from 7.05% in Q2 2024.
Revolution Medicines (RVMDW) Return on Sales (2019 - 2024) Analysis & Trends
Revolution Medicines' Return on Sales history runs 6 years deep, the most recent figure standing at 7.69% for Q3 2024.
- In Q3 2024, Return on Sales fell 757.0% year-over-year to 7.69%; the TTM figure through Sep 2024 stood at 7.69% (down 757.0% YoY), while the FY2023 annual figure was 0.38%, down 31.0% from the prior year.
- Return on Sales for Q3 2024 stood at 7.69%, down from 7.05% in the prior quarter.
- The five-year high for Return on Sales was 0.02% in Q1 2020, with the low at 7.69% in Q3 2024.
- The 5-year median for Return on Sales is 0.08% (2022), against an average of 1.03%.
- The sharpest annual moves came in 2022 and 2024: Return on Sales increased 26 bps in 2022, then slumped 757 bps in 2024.
- Revolution Medicines' Return on Sales stood at 0.04% in 2020, then sank by 42 bps to 0.06% in 2021, then jumped by 34 bps to 0.04% in 2022, then tumbled by 5945 bps to 2.23% in 2023, then sank by 245 bps to 7.69% in 2024.
- Business Quant data shows RVMDW's Return on Sales at 7.69% in Q3 2024, 7.05% in Q2 2024, and 1.07% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -7.69% |
| Jun 30, 2024 | -7.05% |
| Mar 31, 2024 | -1.07% |
| Dec 31, 2023 | -2.23% |
| Sep 30, 2023 | -0.13% |
| Jun 30, 2023 | -0.26% |
| Mar 31, 2023 | -0.10% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | -0.07% |
| Mar 31, 2022 | -0.08% |
| Dec 31, 2021 | -0.06% |
| Sep 30, 2021 | -0.48% |
| Jun 30, 2021 | -0.05% |
| Mar 31, 2021 | -0.04% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.03% |
| Mar 31, 2020 | -0.02% |
| Dec 31, 2019 | -0.02% |